Altered recombinases for genome modification
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorMichele Pamela Calos
Life of this patent
Estimating the term…
Abstract
The present invention describes methods of identifying altered recombinases and compositions thereof, wherein at least one amino acid is different from a parent, wild-type recombinase and the altered recombinase has improved recombination efficiency towards wild-type and/or pseudo att site sequences relative to the parent, wild-type recombinase. The present invention also includes methods of modifying the genomes of cells using the altered recombinases, including methods of site-specifically integrating a polynucleotide sequence of interest in a genome of a eucaryotic cell.
Claims4
A nucleic acid encoding an altered unidirectional site-specific bacteriophage integrase chosen from the group consisting of SEQ ID NO:22, SEQ ID NO:23, and SEQ ID NO:24, that has integrase activity,
- wherein said altered unidirectional site-specific bacteriophage integrase has improved recombination efficiency towards wild-type or pseudo attachment sites as compared to a corresponding wild-type unidirectional site-specific bacteriophage integrase.
An expression cassette, comprising:
- (a) a transcriptional initiation region functional in an expression host;
- (b) a nucleic acid encoding an altered unidirectional site-specific bacteriophage integrase chosen from the group consisting of SEQ ID NO:22, SEQ ID NO:23, and SEQ ID NO:24, that has integrase activity, wherein said altered unidirectional site-specific bacteriophage integrase has improved recombination efficiency towards wild-type or pseudo attachment sites as compared to a corresponding wild-type unidirectional site-specific bacteriophage integrase, and
- (c) a transcriptional termination region functional in said expression host.
A kit comprising:
- a nucleic acid encoding an altered unidirectional site-specific bacteriophage integrase chosen from the group consisting of SEQ ID NO:22, SEQ ID NO:23, and SEQ ID NO:24, that has integrase activity,
- wherein said altered unidirectional site-specific bacteriophage integrase has improved recombination efficiency towards wild-type or pseudo attachment sites as compared to a corresponding wild-type unidirectional site-specific bacteriophage integrase, and instructions for using said nucleic acid.
Dependencies are inferred from the claim text.